Home > Balance Sheet > BIOCON

BIOCON
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹100 Cr₹74 Cr₹81 Cr₹-241 Cr₹-275 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BIOCON ?

The latest Deferred Tax Assets / Liabilities ratio of BIOCON is ₹100 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹100 Cr
Mar2024₹74 Cr
Mar2023₹81 Cr
Mar2022₹-241 Cr
Mar2021₹-275 Cr

How is Deferred Tax Assets / Liabilities of BIOCON Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹100 Cr
34.77
Mar2024 ₹74 Cr
-8.17
Mar2023 ₹81 Cr
Positive
Mar2022 ₹-241 Cr
Negative
Mar2021 ₹-275 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹48,693.5 Cr 6.5% -8.2% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,667.0 Cr 1.2% -4.2% -5.7% Stock Analytics
DIVIS LABORATORIES ₹163,697.0 Cr 3% -9.1% 31.5% Stock Analytics
CIPLA ₹126,365.0 Cr 4.1% 5.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,639.0 Cr 1.1% 4.3% 8.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,479.0 Cr 3.7% 0.1% -7.4% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

6.5%

-8.2%

9.7%

SENSEX

1.8%

-1.7%

2.9%


You may also like the below Video Courses